Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 2 , Pages 194-203 , February 2012

A novel dextran-oleate-cRGDfK conjugate for self-assembly of nanodrug

  • Zhe Wang, PhD
    • ,
  • Ting Yee Lee, BSc
    • ,
  • Paul C. Ho, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author: Laboratory for Experimental and Applied Pharmacokinetics and Pharmacodynamics (LEAP2), Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.

Received 21 March 2011 ,Accepted 5 June 2011.

References 

  1. Langer R. Perspective: drug delivery––drugs on target. Science. 2001;293:58–59
  2. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83:761–769
  3. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161–171
  4. Zolnik BS, Burgess DJ. Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres. J Control Release. 2008;127:137–145
  5. Pulkkinen M, Pikkarainen J, Wirth T, Tarvainen T, Haapa-Acho V, Korhonen H, et al. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: formulation development and in vitro anticancer activity. Eur J Pharm Biopharm. 2008;70:66–74
  6. Gomez JMM, Csaba N, Fischer S, Sichelstiel A, Kundig TM, Gander B, et al. Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J Control Release. 2008;130:161–167
  7. Guerrero S, Muniz E, Teijon C, Olmo R, Teijon JM, Blanco MD. Ketotifen-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers: characterization and in vivo evaluation. J Pharm Sci. 2008;97:3153–3169
  8. Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Delivery Rev. 2007;59:718–728
  9. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Delivery Rev. 1997;28:5–24
  10. Wang Z, Chui WK, Ho PC. Integrin targeted drug and gene delivery. Expert Opin Drug Deliv. 2010;7:159–171
  11. Barone PW, Strano MS. Reversible control of carbon nanotube aggregation for a glucose affinity sensor. Angew Chem Int Edn Engl. 2006;45:8138–8141
  12. Goodwin AP, Tabakman SM, Welsher K, Sherlock SP, Prencipe G, Dai HJ. Phospholipid-dextran with a single coupling point: a useful amphiphile for functionalization of nanomaterials. J Am Chem Soc. 2009;131:289–296
  13. Hennenfent KL, Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle?. Ann Oncol. 2006;17:735–749
  14. Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer. 2008;99:392–397
  15. Ananthapadmanabhan KP, Goddard ED, Turro NJ, Kuo PL. Fluorescence probes for critical micelle concentration. Langmuir. 1985;1:352–355
  16. Ydens I, Rutot D, Degee P, Six JL, Dellacherie E, Dubois P. Controlled synthesis of poly(epsilon-caprolactone)-grafted dextran copolymers as potential environmentally friendly surfactants. Macromolecules. 2000;33:6713–6721
  17. Temming K, Meyer DL, Zabinski R, Dijkers ECF, Poelstra K, Molema G, et al. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels. Bioconjugate Chem. 2006;17:1385–1394
  18. Schiffelers RM, Koning GA, ten Hagen TLM, Fens M, Schraa AJ, Janssen A, et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release. 2003;91:115–122
  19. Bibby DC, Talmadge JE, Dalal MK, Kurz SG, Chytil KM, Barry SE, et al. Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice. Int J Pharm. 2005;293:281–290
  20. Fahmy TM, Samstein RM, Harness CC, Saltzman WM. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials. 2005;26:5727–5736
  21. Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-Sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem. 2007;18:1131–1139
  22. Wang Z, Chui WK, Ho PC. Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res. 2009;26:1162–1171
  23. Jasseron S, Contino-Pepin C, Maurizis JC, Rapp M, Pucci B. Synthesis and preliminary biological assessments of RGD bearing biocompatible telomers. Bioorg Med Chem Lett. 2002;12:1067–1070

☆ This research is supported by Academic Research Funding grants R148-000-097-112 and R148-000-128-112 from the National University of Singapore.

PII: S1549-9634(11)00259-0

doi: 10.1016/j.nano.2011.06.006

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 2 , Pages 194-203 , February 2012

Article Tools

* Image Usage & Resolution